Uscom Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Uscom şirketinin toplam hissedar öz sermayesi A$3.1M ve toplam borcu A$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$5.1M ve A$2.1M dir.

Anahtar bilgiler

Borç/özkaynak oranı

AU$0

Borç

Faiz karşılama oranı	n/a
Nakit	AU$2.52m
Eşitlik	AU$3.06m
Toplam yükümlülükler	AU$2.07m
Toplam varlıklar	AU$5.13m

Son finansal sağlık güncellemeleri

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: UCM 'nin kısa vadeli varlıkları ( A$3.9M ) kısa vadeli yükümlülüklerini ( A$1.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: UCM şirketinin kısa vadeli varlıkları ( A$3.9M ) uzun vadeli yükümlülüklerini ( A$795.0K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: UCM borçsuzdur.

Borcun Azaltılması: UCM un 5 yıl önce borcu yoktu.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: UCM şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: UCM serbest nakit akışı her yıl % 2.7 1.8 yıl yetecek nakit akışına sahip olacaktır.

Uscom Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Uscom Limited to Be Deleted from Other OTC

Recent updates

Less than half of directors are independent

Uscom Limited, Annual General Meeting, Oct 25, 2024

New minor risk - Financial data availability

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited has filed a Follow-on Equity Offering in the amount of AUD 2.014212 million.

Uscom Limited, Annual General Meeting, Oct 26, 2023

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited (ASX:UCM) announces an Equity Buyback for 19,676,833 shares, representing 9.91% for AUD 1.08 million.

Less than half of directors are independent

First half 2023 earnings released: AU$0.008 loss per share (vs AU$0.006 loss in 1H 2022)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited, Annual General Meeting, Nov 10, 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Uscom Limited to Be Deleted from Other OTC

Less than half of directors are independent

Uscom Limited Releases Details of A Study Confirming the High Accuracy of the Uscom BP+ Central Blood Pressure Monitor

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020)

Uscom Limited Announces Five New Software Copyrights for BP Plus in China

Founder recently bought AU$102k worth of stock

Non-Executive Director recently bought AU$145k worth of stock

Uscom Limited Announces Two New USCOM Monitors Get Australian Tga Clearance

Uscom Limited Announces SpiroSonic Air Approved for European Ce Mark

Uscom Limited Announces Two New Uscom Devices for China

First half 2021 earnings released: AU$0.002 loss per share (vs AU$0.011 loss in 1H 2020)

Uscom Limited Appoints MedCaT as New European Distributor

Uscom Limited announced that it has received funding

Full year earnings released - AU$0.009 loss per share

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin